ClinicalTrials.gg
Status unknownNCT05805761Updated Aug 3, 2023

Antimicrobial Photodynamic Therapy With Erythrosine and Blue Light on Dental Biofilm Bacteria

A Phase 1/2 interventional study of Conventional Treatment and Antimicrobial Photodynamic Therapy in Dental Plaque, sponsored by University of Nove de Julho. Status unknown. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-03.

Sponsored by University of Nove de Julho · Phase 1/2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 1/2
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The objective of this study is to investigate the effect of Antimicrobial Photodynamic Therapy mediated by Erythrosine and blue LED in the reduction of bacteria in dental biofilm. This clinical trial will be carried out with 30 patients who have biofilm, but without the presence of periodontal pockets, and who are being treated at the Dental Clinic of Universidade Metropolitana de Santos. A split-mouth model will be used (n = 30), with group I control - conventional treatment and group II - conventional treatment and antimicrobial photodynamic therapy (aPDT). The bicarbonate jet will be used to remove dental biofilm in both groups. The treatment will be carried out in 1 session. aPDT will be performed before cleaning/prophylaxis, only in group II. Participants will rinse with the photosensitizer erythrosine (diluted to 1mM) for 1 min of pre-irradiation time, so that the drug can stain all the bacterial biofilm. Then, the D-2000 LED (DMC) will be applied, emitting at a wavelength of ʎ = 430-490 nm and 900-1100 mW/cm2. Irradiation will be performed until the biofilm of the cervical region is illuminated for 2 min per point. Each irradiation point will be approximately 0.4 cm2. The microbiological examination will be performed from samples of supragingival biofilm collected from the gingival sulcus. Two collections will be performed in each experimental site before irradiation, and immediately after the irradiation procedure (group II) or prophylaxis (groups I and II). Biofilm samples will be collected before and after exposure, respectively, and sent to the microbiological laboratory for colony counting. After this period, the CFU's will be counted and the data will be submitted to statistical analysis for comparison of pre and post-treatment results and between groups (conventional X aPDT).

02

Conditions studied

  • Dental Plaque

Browse trials for

03

In context

Dental Plaque

322 studies on the registry are indexed under Dental Plaque; 54 are open to participants now.

This study's planned enrollment of 30 is below the median of 59 across 286 interventional studies indexed under Dental Plaque.

Browse Dental Plaque studies →

Lead sponsor

University of Nove de Julho is the lead sponsor of 246 studies on the registry; 52 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 1 (13%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The participant must present between 25% and 50% of biofilm index;
  • Have at least 20 teeth present, without clinical probing depths greater than 3 mm.

Exclusion criteria

Exclusion Criteria:

  • Smokers;
  • Uncontrolled diabetics or hypertensives;
  • Cancer or its treatment;
  • Pregnant women;
  • Use of antibiotics in the last 6 months;
  • Coagulation disorders (use of anticoagulants, presence of liver diseases, thrombocytopenia and immunosuppression);
  • Patients undergoing orthodontic treatment.
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Conventional Treatment Group

    Participants in this group will receive the conventional treatment for the removal of dental biofilm (prophylaxis with bicarbonate jet).

    Procedure: Conventional Treatment

  • Experimental
    aPDT + Conventional Treatment Group

    Participants in this group will receive both the antimicrobial photodynamic therapy and the conventional treatment (prophylaxis with bicarbonate jet) for the removal of dental biofilm.

    Procedure: Conventional Treatment · Procedure: Antimicrobial Photodynamic Therapy

Interventions

  • ProcedureConventional Treatment

    A bicarbonate jet will be used to remove the biofilm from the surface of the teeth.

  • ProcedureAntimicrobial Photodynamic Therapy

    aPDT will be performed before each cleaning/prophylaxis session, only in one of the groups. Participants will swish with the photosensitizer erythrosine for 1 min of pre-irradiation time, so that the drug can stain all the bacterial biofilm. The D-2000 LED (DMC) will be applied, emitting at a wavelength of ʎ = 430-490 nm and 900-1100 mW/cm2. Irradiation will be performed until the biofilm of the cervical region is illuminated for 2 min per point. Each irradiation point will be approximately 0.4 cm2.

06

What researchers measure

Primary outcomes

  1. Changes in Colony Forming Units

    The microbiological examination will be carried out from biofilm samples collected from the gingival sulcus. Two collections will be performed in each experimental site before irradiation, and immediately after the prophylaxis procedure or irradiation. To collect the subgingival biofilm, the teeth will be isolated with cotton rolls, the supragingival biofilm will be removed with sterile gauze, and the subgingival biofilm sample will be obtained by introducing a tip of sterile absorbent paper (#30) inside of the periodontal pocket, being kept in position for 30 s. The tips will be removed and stored in properly identified sterile plastic microtubes, each tube containing 1 mL of sterile Brain Heart Infusion (BHI) culture medium will be packed on ice and analyzed immediately after collection. The samples will be used to determine the CFU's (Colony Forming Units). Each tube with 1 mL BHI will be vortexed and will undergo serial dilution from 10-1 to 10-5 times the original concentration.

    Time frame: Baseline and immediately after treatment.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Goncalves MLL, Sobral APT, Gallo JMAS, Gimenez T, Ferri EP, Ianello S, Motta PB, Motta LJ, Horliana ACRT, Santos EM, Bussadori SK. Antimicrobial photodynamic therapy with erythrosine and blue light on dental biofilm bacteria: study protocol for randomised clinical trial. BMJ Open. 2023 Sep 19;13(9):e075084. doi: 10.1136/bmjopen-2023-075084. PubMed 37730405 ↗

Individual participant data

Plan to share: Yes — The data sets generated in the study will be available from the corresponding author at a reasonable request. Once the data is entered electronically, participants identification details will no longer be attached to their data, they will be reported only by numbers. After the analysis of the data, volunteers will be invited to a meeting and the results will be shared, in case they wish to attend it. The authors intend to publish the results in a peer-review jornal and present them in cientific events.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2023; primary completion for Nov 2023, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 28, 2023
First posted
Apr 10, 2023
StartEst.
Aug 20, 2023
Primary completionEst.
Nov 20, 2023
CompletionEst.
Dec 20, 2023
Last update
Aug 3, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05805761
Responsible party
Marcela Leticia Leal Gonçalves (Principal Investigator, University of Nove de Julho) — Principal investigator
First posted
Apr 10, 2023
Start date
Aug 20, 2023 (estimated)
Primary completion
Nov 20, 2023 (estimated)
Completion
Dec 20, 2023 (estimated)
Last update
Aug 3, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion